A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.
Huberman, M
A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors. [electronic resource] - Cancer Oct 1991 - 1708-13 p. digital
Publication Type: Clinical Trial; Journal Article
0008-543X
10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v doi
Adult
Aged
Drug Administration Schedule
Drug Evaluation
Eosinophils
Female
Follow-Up Studies
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Interleukin-2--administration & dosage
Leukocyte Count--drug effects
Lymphatic Metastasis
Lymphocytes
Male
Middle Aged
Neoplasms--blood
Recombinant Proteins--administration & dosage
Remission Induction
A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors. [electronic resource] - Cancer Oct 1991 - 1708-13 p. digital
Publication Type: Clinical Trial; Journal Article
0008-543X
10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v doi
Adult
Aged
Drug Administration Schedule
Drug Evaluation
Eosinophils
Female
Follow-Up Studies
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Interleukin-2--administration & dosage
Leukocyte Count--drug effects
Lymphatic Metastasis
Lymphocytes
Male
Middle Aged
Neoplasms--blood
Recombinant Proteins--administration & dosage
Remission Induction